# SLC9B2

## Overview
The SLC9B2 gene encodes the protein solute carrier family 9 member B2, commonly referred to as NHA2, which is a member of the sodium/hydrogen exchanger family. This protein plays a pivotal role in maintaining intracellular pH and cell volume by facilitating the exchange of sodium and hydrogen ions across cellular membranes. NHA2 is characterized by its structure, which includes 14 transmembrane helices and forms homodimers, a feature critical for its function (Matsuoka2022Structure; Anderegg2022The). It is predominantly expressed in the kidney and pancreatic β-cells, where it influences processes such as sodium reabsorption and insulin secretion, respectively (Anderegg2022The; Ho2022Physiological). The protein's activity is essential for various physiological functions, including blood pressure regulation and glucose homeostasis, and its dysregulation is implicated in conditions such as Gitelman's syndrome and type 2 diabetes (Anderegg2022The; Ho2022Physiological).

## Structure
The SLC9B2 gene encodes the NHA2 protein, a member of the sodium/hydrogen exchanger family, which is involved in intracellular pH and cell volume regulation. The primary structure of NHA2 includes a sequence that forms 14 transmembrane helices (TMHs), with an additional N-terminal helix, TM -1, contributing to its unique dimerization structure (Matsuoka2022Structure; Anderegg2022The). The secondary structure is characterized by the 'NhaA-fold', which includes two discontinuous helices, TM5a-b and TM12a-b, that cross over near the membrane center (Matsuoka2022Structure).

The tertiary structure of NHA2 involves a core domain in an outward-facing conformation, with specific residues such as Asp277 and Asp278 playing crucial roles in ion binding (Matsuoka2022Structure). The quaternary structure is defined by the formation of homodimers, facilitated by the TM -1 helix interacting with TM8 and the TM8-TM9 loop of the neighboring protomer (Matsuoka2022Structure).

NHA2's structure is stabilized by lipid interactions, particularly with phosphatidylinositol and phosphatidylinositol diphosphate, which are crucial for the stability of the dimerization subdomain (Anderegg2022The). The protein's activity is influenced by pH changes, and it does not transport K+ or Cl- ions, unlike its closely related isoform NHA1 (Matsuoka2022Structure).

## Function
The SLC9B2 gene encodes the NHA2 protein, a member of the sodium/hydrogen exchanger family, which plays a crucial role in ion transport across cellular membranes. NHA2 is involved in regulating intracellular pH and cell volume, primarily through its function as a sodium/hydrogen exchanger. This protein is expressed in various tissues, including the kidney, where it is localized in the distal convoluted tubules. Here, it contributes to sodium and chloride reabsorption, impacting extracellular volume and blood pressure regulation (Anderegg2022The; Ho2022Physiological).

NHA2 is also significantly expressed in β-cells of the pancreas, where it influences insulin secretion. Knockdown studies in β-cells have shown that reduced NHA2 expression leads to decreased insulin secretion, highlighting its role in glucose homeostasis (Anderegg2022The; Ho2022Physiological). Additionally, NHA2 is implicated in clathrin-dependent endocytosis in β-cells, affecting the coupling of endo-exocytosis processes (Ho2022Physiological).

In the context of cellular localization, NHA2 is found in the cytoplasmic membrane and inner mitochondrial membrane, where it facilitates the exchange of Na+/H+ and Na+/Li+ ions, contributing to mitochondrial function and ion homeostasis (Knyazev2018TNFαInduced).

## Clinical Significance
Mutations and alterations in the expression of the SLC9B2 gene, which encodes the sodium/hydrogen exchanger NHA2, have been implicated in several clinical conditions. NHA2 is associated with blood pressure regulation and renal electrolyte handling. Knockout studies in mice have shown that the absence of NHA2 can lead to symptoms resembling Gitelman's syndrome, a condition characterized by hypovolemia and reduced blood pressure due to the downregulation of the WNK4-SPAK-NCC axis in distal convoluted tubule cells (Anderegg2022The; Ho2022Physiological).

NHA2 is also linked to systemic glucose homeostasis. Its expression in β-cells is crucial for insulin secretion, and knockdown of NHA2 results in reduced insulin release, leading to impaired glucose tolerance. This has implications for type 2 diabetes, as a single-nucleotide polymorphism in NHA2 has been associated with the disease (Anderegg2022The; Ho2022Physiological).

In polycystic kidney disease (PKD), NHA2 is significantly upregulated and contributes to cyst development. Its expression is regulated by intracellular calcium signaling and cAMP levels, which are central to PKD pathophysiology. Targeting NHA2 could offer therapeutic potential for managing PKD (Anderegg2022The; Prasad2018NHA2).


## References


[1. (Anderegg2022The) Manuel A. Anderegg, Gergely Gyimesi, Tin Manh Ho, Matthias A. Hediger, and Daniel G. Fuster. The less well-known little brothers: the slc9b/nha sodium proton exchanger subfamily—structure, function, regulation and potential drug-target approaches. Frontiers in Physiology, May 2022. URL: http://dx.doi.org/10.3389/fphys.2022.898508, doi:10.3389/fphys.2022.898508. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2022.898508)

[2. (Knyazev2018TNFαInduced) E. N. Knyazev, D. V. Mal’tseva, A. A. Zacharyants, G. S. Zakharova, O. V. Zhidkova, and A. A. Poloznikov. Tnfα-induced expression of transport protein genes in huvec cells is associated with enhanced expression of transcription factor genes relb and nfkb2 of the non-canonical nf-κb pathway. Bulletin of Experimental Biology and Medicine, 164(6):757–761, April 2018. URL: http://dx.doi.org/10.1007/s10517-018-4074-1, doi:10.1007/s10517-018-4074-1. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10517-018-4074-1)

[3. (Matsuoka2022Structure) Rei Matsuoka, Roman Fudim, Sukkyeong Jung, Chenou Zhang, Andre Bazzone, Yurie Chatzikyriakidou, Carol V. Robinson, Norimichi Nomura, So Iwata, Michael Landreh, Laura Orellana, Oliver Beckstein, and David Drew. Structure, mechanism and lipid-mediated remodeling of the mammalian na+/h+ exchanger nha2. Nature Structural &amp; Molecular Biology, 29(2):108–120, February 2022. URL: http://dx.doi.org/10.1038/s41594-022-00738-2, doi:10.1038/s41594-022-00738-2. This article has 33 citations.](https://doi.org/10.1038/s41594-022-00738-2)

[4. (Ho2022Physiological) Tin Manh Ho, Stephan Berger, Philipp Müller, Céline Simonin, Jean-Louis Reymond, Christoph Von Ballmoos, and Daniel G. Fuster. Physiological and molecular function of the sodium/hydrogen exchanger nha2 (slc9b2). CHIMIA, 76(12):1019, December 2022. URL: http://dx.doi.org/10.2533/chimia.2022.1019, doi:10.2533/chimia.2022.1019. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.2533/chimia.2022.1019)

[5. (Prasad2018NHA2) Hari Prasad, Donna K. Dang, Kalyan C. Kondapalli, Niranjana Natarajan, Valeriu Cebotaru, and Rajini Rao. Nha2 promotes cyst development in an in vitro model of polycystic kidney disease. The Journal of Physiology, 597(2):499–519, October 2018. URL: http://dx.doi.org/10.1113/JP276796, doi:10.1113/jp276796. This article has 15 citations.](https://doi.org/10.1113/JP276796)